Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Annex 1 Considerations for Fill/Finish

September 02, 2019

Equipment and systems for aseptic transfer and manufacture meet cGMP and Annex 1 requirements for pharmaceutical fill and finish.

The Road to Real-Time Release: At-line NIR Testing

September 02, 2019

At-line NIR measurements can replace a laboratory HPLC measurement for API content in oral solid-dosage drug manufacturing.

Industry Experiences in Continuous Manufacturing for Encapsulation and Tableting

September 02, 2019

Early adopters of continuous manufacturing approaches shared their plans and some of their experiences at the 11th annual Charles Jarowski Symposium in Industrial Pharmacy.

Plan Now to Share Your Expertise in 2020

September 02, 2019

The editors welcome technical article contributions from the bio/pharma industry.

Seeking Solutions for Large-Scale GMP Viral Vector Manufacturing

September 02, 2019

Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies.

Alvotech, Prestige Biopharma Form New Manufacturing Partnership

August 30, 2019

Alvotech and Prestige Biopharma, have announced the formation of a new contract manufacturing partnership for the commercial production of a biosimilar.

Australian Researchers Successfully Develop New Tuberculosis Vaccine

August 30, 2019

Medical researchers from the Centenary Institute and the University of Sydney in Australia have managed to successfully develop and test a new vaccine targeting tuberculosis.

FDA Expands Scope of API Impurity Investigation

August 29, 2019

While downgrading the impact of nitrosamine impurities on patients, FDA vows to step up investigations for other drug types.

J&J Vows to Appeal $572-million Opioid Decision

August 27, 2019

A ruling in Oklahoma that Johnson & Johnson’s marketing efforts created a public nuisance may establish a precedent of other jurisdictions.

Industry Stresses Importance of Tackling Vaccine Hesitancy

August 23, 2019

ABPI has issued a statement of support in response to the United Kingdom’s Prime Minister’s recent order of urgent action to boost the numbers of children receiving vaccinations.